DRD1 and metabolic syndrome: In addition, the reversible phenotypes upon D1R agonist treatment suggest that the reduced D1R numbers on the plasma membrane could be the primary cause of MetS in the ros mutant mice, although we have not excluded the effects on the substantia nigra and olfactory bulb where SLC35D3 are also expressed (Fig. 3A).